Maternal soluble PD-1 levels are significantly increased in women with preeclampsia.
Yang GuJohn MorganDavid F LewisDanielle B CooperCharles E McCathranYuping WangPublished in: American journal of reproductive immunology (New York, N.Y. : 1989) (2019)
Aberrant sPD-1/sPD-L1 signaling is present in preeclampsia. Whether increased maternal sPD-1 and sPD-L1 levels were associated with fetal gender difference or immune tolerance dissimilarity during pregnancy in women with preeclampsia warrants further investigation.